Literature DB >> 25439535

Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and the kidneys.

Saadur Rahman1, Anthony Malcoun2.   

Abstract

Nonsteroidal antiinflammatory drugs (NSAIDs) are one of the most commonly used classes of medications in the world, which function by inhibiting the cyclooxygenase (COX) enzymes and downregulating the inflammatory pathway. COX enzymes are constitutively expressed in the kidneys and function to maintain a homeostatic environment in terms of maintaining the glomerular filtration rate, blood pressure, sodium, water, and osmotic regulation. When the COX enzymes are inhibited by NSAIDs, a multitude of renal and vascular complications occur. This article aims to enlighten primary care physicians of the complications that arise with NSAIDs from a renal perspective and to present some management strategies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; COX-1; COX-2; Electrolytes; Glomerular filtration rate; Hypertension; Kidneys; NSAIDS

Mesh:

Substances:

Year:  2014        PMID: 25439535     DOI: 10.1016/j.pop.2014.09.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  5 in total

1.  Practice guidelines for pharmacists: The management of osteoarthritis.

Authors:  Jason Kielly; Erin M Davis; Carlo Marra
Journal:  Can Pharm J (Ott)       Date:  2017-05-01

Review 2.  [Choosing wisely recommendations in nephrology].

Authors:  J Galle; J Floege
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

3.  Long-term Assessment of NSAID Prescriptions and Potential Nephrotoxicity Risk in Adult Kidney Transplant Recipients.

Authors:  Jordan M Chiasson; Cory E Fominaya; Mulugeta Gebregziabher; David J Taber
Journal:  Transplantation       Date:  2019-12       Impact factor: 4.939

4.  Effects of NSAIDs on kidney functions and cardiovascular system.

Authors:  Yusuf Ziya Şener; Metin Okşul
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-08       Impact factor: 3.738

5.  A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study.

Authors:  Jonathan Brett; Adam G Elshaug; R Sacha Bhatia; Kelsey Chalmers; Tim Badgery-Parker; Sallie-Anne Pearson
Journal:  Implement Sci       Date:  2017-05-03       Impact factor: 7.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.